Forward focused thinking
Blue Latitude Health’s consultancy is based on a rich vein of expert knowledge. Here you’ll find thought-provoking commentary, articles, and downloadable resources created by our consultants.
Explore our ideas and get a deeper understanding of the current and future trends in healthcare:
Filter articles
Brand teams: They're not what you think they are
|19th February 2016
Pharma still has silos around key functions in the marketing process, which has the unintended consequence of often putting these functions at odds with the brand teams. In 2016, it’s time to bring these teams together and move them toward a common goal – delivering for your customers to enable better patient outcomes. Head of Commercial Matt Bolton breaks down what we mean when we talk about eliminating the last silos in pharma marketing.
Why are doctors frustrated with the digitalisation of healthcare?
|15th February 2016
Healthcare is not a consumer-driven market where we can assume that patient-centred innovations will automatically influence adoption within doctor communities. In this article, Customer Experience Consultant Anna Tamasi highlights the most common usability and user experience implications that the digitalisation of healthcare poses on doctors' professional lives.
What pharma needs to know about genomic data in 2016
|3rd February 2016
About ten years ago, personalised medicine was a major step forward – tailoring treatments based on individual patient history and information. Fast forward to 2015, and investigating the central dogma of biology is still a major focus of healthcare research.
Consultant David Cooney talks us through what this progress in genomics means for pharma in 2016.
Content Strategy for pharma: Maturing your approach in 2016
|26th January 2016
The way that many pharma and healthcare brands think about content strategy – the creation, management, storage, and governance of content – hasn’t matured in quite the same way as multichannel marketing strategy.
In this article, Consultant Adwoa Baah and Content Marketing Manager Liz Inskip take us through three things pharma can do to improve content strategy maturity within their organisations in 2016.
Should we rethink ‘insight’ in healthcare?
|20th January 2016
Like other sectors, healthcare relies on insight. Therefore, it isn’t immune to the factors that affect the likelihood of a business to reach meaningful insight.
Head of Insight Martine Leroy explains why it's time to rethink what 'insight' means in healthcare.
How to surf the healthcare disruption tsunami
|12th January 2016
Moving into 2016, we want to draw the focus to the issue of tangibly defining value in healthcare innovation and ensuring that the services that pharma and healthcare brands are developing are actually taken up and implemented. Managing Consultant James Atherton talks through some tangible tips for businesses and brands looking to surf the wave of disruption in 2016.
Regional campaigns: Improving local uptake while staying on-message
|22nd October 2015
Localising global and regional campaigns is a challenge all global organisations face. However, for healthcare brands, it can be even more challenging because local regulations and systems can be so variable and complicated. Account Director Dolan Desai talks us through five core considerations that will allow you to maximise impact across a region through coherent execution.
10 tips for developing insightful pre-launch positioning
|8th October 2015
By getting your positioning right, you can build the motivational, aspirational, and resonant brand story and messaging that will allow your product to become a brand. Head of Insight Martine Leroy delivers her top tips on how to keep insight at the centre of your positioning to best support your brand.
Bigger than brand: Portfolio positioning for pharma
|29th September 2015
With pharma in the midst of a patent cliff, portfolios of treatments are becoming more and more common, and the need for a clear co-positioning strategy has never been greater.
Head of Brand Strategy Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.
Tackling biosimilars – how to handle the threat to pharma brands
|23rd September 2015
Recently, Blue Latitude Health worked with a global pharmaceutical brand to develop a strategy for dealing with the introduction of biosimilars to the market. Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch. Strategy Consultant Mark Assenti talks through three key points for developing a strategy to tackle biosimilars.
Previous
